CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
Ki-Chang Lee, Jiwon Koh, Doo Hyun Chung, Yoon Kyung Jeon
JPTM. 2021;55(2):139-144.   Published online 2021 January 22    DOI: https://doi.org/10.4132/jptm.2020.12.16

Excel Download

A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
Journal of Pathology and Translational Medicine. 2021;55(2):139-144   Crossref logo
Link1 Link2 Link3

Treatment Strategy of Lung Adenocarcinoma with Concomitant EGFR Mutation and ALK Rearrangement
. 2021;   Crossref logo
Link1 Link2

Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: Report of a case and review of the literature with demonstration of genes alteration into the same tumor cells
Lung Cancer. 2014;86(2):291-295   Crossref logo
Link1 Link2

EGFR exon 18 delE709_T710insD mutated stage IV lung adenocarcinoma with response to afatinib
Lung Cancer. 2017;108:45-47   Crossref logo
Link1 Link2

Efficacy Differences of First-line EGFR-TKIs Alone vs. in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alteration(s)
. 2021;   Crossref logo
Link1 Link2

Gefitinib
Reactions Weekly. 2017;1675(1):117-117   Crossref logo
Link1 Link2 Link3

Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
Diagnostic Pathology. 2020;15(1):   Crossref logo
Link1 Link2 Link3

Gefitinib
Reactions Weekly. 2019;1778(1):214-214   Crossref logo
Link1 Link2 Link3

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI
Lung Cancer. 2013;82(1):177-178   Crossref logo
Link1 Link2

Dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CML
Case Reports in Oncological Medicine. 2020;2020:1-6   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.